Exploring the Anticancer Effect of <i>Artemisia herba‐alba</i> on Colorectal Cancer: Insights From Eight Colorectal Cancer Cell Lines
Colorectal cancer (CRC) is a prevalent and deadly disease, necessitating the exploration of novel therapeutic strategies. Traditional chemotherapy often encounters drug resistance and adverse side effects, highlighting the need for alternative approaches. <i>Artemisia herba-alba</i>, a plant rich in phytochemical constituents, was investigated for its potential as an anticancer agent against colorectal cancer (CRC). The primary objective of this study was to investigate the cytotoxic effects of the methanolic extract of <i>A. herba-alba</i> on eight CRC cell lines including: Caco-2, DLD1, RKO<sup>+/+</sup>p53, RKO<sup>-/-</sup>p53, HCT<sup>+/+</sup>p53, HCT<sup>-/-</sup>p53, SW620, and SW480. Specifically, the study investigated the extract's impact on cell viability, apoptosis, cell cycle progression, and effects on the PI3K/AKT/mTOR signaling pathway. Chemical derivatization and Gas Chromatography-Mass Spectrometry (GC-MS) analysis revealed a diverse array of bioactive compounds, including ephedrine, hydroxyflavone, quinolinic acid, 4-hydroxybenzoic acid, borneol, β-eudesmol, and camphor, known for their cytotoxic properties. The methanolic extract of <i>A. herba-alba</i> exhibited varying degrees of cytotoxicity across a panel of CRC cell lines, with IC<sub>50</sub> values indicating differential sensitivity. The extract triggered apoptosis in many cell lines, irrespective of p53 status. Importantly, <i>A. herba-alba</i> extract caused G2-M phase cell cycle arrest in CRC cells, accompanied by a decrease in Cyclin B1 and CDK1 expression. Furthermore, the extract demonstrated an inhibitory effect on the PI3K/AKT/mTOR pathway, crucial in cancer progression. These findings highlight the promising anticancer potential of <i>Artemisia herba-alba</i> as a valuable resource for innovative CRC treatments. Further research is warranted to elucidate its specific anticancer characteristics and explore its potential incorporation into future cancer therapy approaches.
Authors
- Mohammad H. Semreen (ORCID: https://orcid.org/0000-0002-0169-7538)
- Eman Abu‐Gharbieh (ORCID: https://orcid.org/0000-0002-5972-0681)
- Mohammad Hudaib (ORCID: https://orcid.org/0000-0003-1400-462X)
- Jalal Taneera (ORCID: https://orcid.org/0000-0002-3341-1063)
- Bashaer Abu‐Irmaileh (ORCID: https://orcid.org/0000-0003-1040-3156)
- Yasser Bustanji (ORCID: https://orcid.org/0000-0003-1315-0609)
- Hamza M. Al‐Hroub (ORCID: https://orcid.org/0000-0001-5621-9851)
- Amani A. Harb (ORCID: https://orcid.org/0000-0001-9408-533X)
- Abdallah Shanableh (ORCID: https://orcid.org/0000-0002-9808-4120)
- Leen Eldohaji
- Waseem El‐Huneidi (ORCID: https://orcid.org/0000-0002-1580-2589)
- Wael M. Abdel‐Rahman (ORCID: https://orcid.org/0000-0002-2149-1043)
- Jehad Almaliti (ORCID: https://orcid.org/0000-0002-3562-0846)
- Karem H. Alzoubi (ORCID: https://orcid.org/0000-0002-2808-5099)
- Lara J. Bou Malhab (ORCID: https://orcid.org/0000-0001-7436-346X)
- Ahmad Y. Abuhelwa (ORCID: https://orcid.org/0000-0002-4182-065X)
Institutions
- Al-Ahliyya Amman University (JO)
- University of Jordan (JO)
- University of Sharjah (AE)
- University of California San Diego (US)
- University of Montana (US)
Publication Details
- Journal
- Food Science & Nutrition
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1002/fsn3.4715
- Citations
- 7
- Primary Topic
- Plant chemical constituents analysis
- Type
- article
- Field-Weighted Citation Impact
- 4.20
Funders
- University of Sharjah
- University of Jordan
- Al-Ahliyya Amman University